None listed
Conditions
Interventions
None listed
Sponsors
Hanyang University Seoul Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Aged = 19 years 2) Naïve patients for Sevikar HCT® tablet and who are eligible for the treatment of Sevikar HCT® tablet according to the approved product label 3) Patients who are willing to be prescribed Sevikar HCT® tablet at physician's discretion 4) Hypertensive patients who have at least one of following CV risk factor ?- Age(men=45, women=55) ?- Smoking ?- Dyslipidemia ?- Diabetes mellitus ?- Chronic kidney disease ?- CVD history 5) Patients who give voluntary written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: 1) Patients who are simultaneously participating in the interventional studies could influence the processes and results of this study 2) Patients who were previously administered Sevikar HCT® tablet
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients achieving target BP (<130/80 mmHg) according to 2017 ACC/AHA guideline at 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of patients achieving target BP according to 2013 KSH guideline at 24 weeks;Percentage of patients achieving target BP by risk factor;BP responder* rate (reduction in SBP or DBP (>20/10 mm Hg) );Change in systolic/diastolic BP from baseline;Factors associated with achieving target BP | — |
Countries
Korea, Republic of
Contacts
Public ContactJinho Shin
Hanyang University Seoul Hospital
Outcome results
None listed